Unaltered peripheral excitatory actions of nociceptin contrast with enhanced spinal inhibitory effects after carrageenan inflammation: an electrophysiological study in the rat

Pain

Volumn 85, Issue 3, 2000, Pages 433-441

  Carpenter, Kate J ^a   Vithlani, Mansi ^a   Dickenson, Anthony H ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Inflammation; Nociceptin orphanin FQ; ORL 1 receptor; Peripheral nerve; Spinal cord

Indexed keywords

CARRAGEENAN; HALOTHANE; NALOXONE; NOCICEPTIN;

ACTION POTENTIAL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG SENSITIVITY; INFLAMMATION; MALE; NERVE FIBER C; NERVE POTENTIAL; NONHUMAN; POSTSYNAPTIC POTENTIAL; PRESYNAPTIC NERVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR DENSITY; SPINAL CORD DORSAL HORN;

ANIMALS; CARRAGEENAN; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHYSIOLOGY; EVOKED POTENTIALS; INFLAMMATION; INJECTIONS, SPINAL; NERVE FIBERS; NEURONAL PLASTICITY; OPIOID PEPTIDES; PAIN; PERIPHERAL NERVOUS SYSTEM; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID; SPINAL CORD;

EID: 0034175526     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(99)00301-2     Document Type: Article

References (36)

1. Andoh T., Itoh M., Kuraishi Y. Nociceptin gene expression in rat dorsal root ganglia induced by peripheral inflammation. NeuroReport. 8:1997;2793-2796.
2. 2 is an agonist of the nociceptin (ORL-1) receptor. Eur J Pharmacol. 349:1998;R5-R6.
3. 2, a peripheral ORL-1 receptor antagonist, acts as an agonist in the rat spinal cord. Br J Pharmacol. 125:1998;949-951.
4. Crain S.M., Shen K.F. Opioids can evoke direct receptor-mediated excitatory effects on sensory neurons. Trends Pharmacol Sci. 11:1990;77-81.
5. Devine D.P., Reinscheid R.K., Monsma F.J. Jr, Civelli O., Akil H. The novel neuropeptide orphanin FQ fails to produce conditioned place preference or aversion. Brain Res. 727:1996;225-229.
6. Dickenson A., Knox R. Antagonism of mu opioid receptor mediated inhibitions of nociceptive neurones by U50488H and Dynorphin A(1-13) in the rat dorsal horn. Neurosci Lett. 75:1987;229-234.
7. Faber E.S., Chambers J.P., Evans R.H., Henderson G. Depression of glutamatergic transmission by nociceptin in the neonatal rat hemisected spinal cord preparation in vitro. Br J Pharmacol. 119:1996;189-190.
8. Grisel J.E., Mogil J.S., Belknap J.K., Grandy D.K. Orphanin FQ acts as a supraspinal, but not a spinal, anti-opioid peptide. NeuroReport. 7:1996;2125-2129.
9. Hao J-X., Xu I.S., Wiesenfeld-Hallin Z., Xu X-J. Anti-hyperalgesic and antiallodynic effects of intrathecal nociceptin/orphanin FQ in rats after spinal cord injury, peripheral nerve injury and inflammation. Pain. 76:1998;385-393.
10. Hargreaves K., Dubner R., Brown F., Flores C., Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 32:1988;77-88.
11. Hassan A.H., Ableitner A., Stein C., Herz A. Inflammation of the rat paw enhances axonal transport of opioid receptors in the sciatic nerve and increases their density in the inflamed tissue. Neuroscience. 55:1993;185-195.
12. Helyes Z., Nemeth J., Pinter E., Szolcsanyi J. Inhibition by nociceptin of neurogenic inflammation and release of SP and CGRP from sensory nerve terminals. Br J Pharmacol. 121:1997;613-615.
13. Inoue M., Kobayashi M., Kozaki S., Zimmer A., Ueda H. Nociceptin/orphanin FQ-induced nociceptive responses through substance P release from peripheral nerve endings in mice. Proc Natl Acad Sci. 95:1998;10949-10953.
14. Jia Y-P., Linden D., Serie J., Seybold V. Nociceptin/orphanin FQ binding increases in superficial laminae of the rat spinal cord during persistent peripheral inflammation. Neurosci Lett. 250:1998;21-24.
15. Lai C.C., Wu S.Y., Dun S.L., Dun N.J. Nociceptin-like immunoreactivity in the rat dorsal horn and inhibition of substantia gelatinosa neurons. Neuroscience. 81:1997;887-891.
16. Meunier J-C. Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor. Eur J Pharmacol. 340:1997;1-15.
17. Meunier J-C., Mollereau C., Toll L., Suaudeau C., Moisand C., Alvinerie P., Butour J-L., Guillemot J-C., Ferrara P., Monsarrat B., Mazarguil H., Vassart G., Parmentier M., Costentin J. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature. 377:1995;532-535.
18. Mogil J.S., Grisel J.E., Reinscheid R.K., Civelli O., Belknap J.K., Grandy D.K. Orphanin FQ is a functional anti-opioid peptide. Neuroscience. 75:1996;333-337.
19. Morgan M.M., Grisel J.E., Robbins C.S., Grandy D.K. Antinociception mediated by the periaqueductal gray is attenuated by orphanin FQ. NeuroReport. 8:1997;3431-3434.
20. Nishi M., Houtani T., Noda Y., Mamiya T., Sato K., Doi T., Kuno J., Takeshima H., Nukada T., Nabeshima T., Yamashita T., Noda T., Sugimoto T. Unrestrained nociceptive response and disregulation of hearing ability in mice lacking the nociceptin/orphaninFQ receptor. EMBO J. 16:1997;1858-1864.
21. Pan Z.Z., Tershner S., Fields H. Cellular mechanism for the anti-analgesic action of agonists of the kappa opioid receptor. Nature. 389:1997;382-385.
22. Reinscheid R.K., Nothacker H.P., Bourson A., Ardati A., Henningsen R.A., Bunzow J.R., Grandy D.K., Langen H., Monsma F.J. Jr, Civelli O. Orphanin FQ: a neuropeptide that activates an opioid-like G protein-coupled receptor. Science. 270:1995;792-794.
23. Riedl M., Shuster S., Vulchanova L., Wang J., Loh H.H., Elde R. Orphanin FQ/nociceptin-immunoreactive nerve fibers parallel those containing endogenous opioids in rat spinal cord. NeuroReport. 7:1996;1369-1372.
24. Rossi G.C., Leventhal L., Pasternak G.W. Naloxone sensitive orphanin FQ-induced analgesia in mice. Eur J Pharmacol. 311:1996;R7-R8.
25. Saito Y., Maruyama K., Kawano H., Hagino-Yamagishi K., Kawamura K., Saido T.C., Kawashima S. Molecular cloning and characterization of a novel form of neuropeptide gene as a developmentally regulated molecule. J Biol Chem. 271:1996;15615-15622.
26. Shen K.F., Crain S.M. Cholera toxin-B subunit blocks excitatory effects of opioids on sensory neuron action potentials indicating that GM1 ganglioside may regulate Gs-linked opioid receptor functions. Brain Res. 531:1990;1-7.
27. Stanfa L., Dickenson A. Spinal opioid systems in inflammation. Inflamm Res. 44:1995;231-241.
28. Stanfa L.C., Chapman V., Kerr N., Dickenson A.H. Inhibitory action of nociceptin on spinal dorsal horn neurones of the rat, in vivo. Br J Pharmacol. 118:1996;1875-1877.
29. Stein C. Interaction of immune-competent cells and nociceptors. Gebhart G., Hammond D., Jensen T. Progress in pain management, vol. 2, Proceedings of the VIIth World Congress on Pain. 1994;285-297 IASP Press, Seattle.
30. Tian J.H., Xu W., Fang Y., Mogil J.S., Grisel J.E., Grandy D.K., Han J.S. Bidirectional modulatory effect of orphanin FQ on morphine-induced analgesia: antagonism in brain and potentiation in spinal cord of the rat. Br J Pharmacol. 120:1997;676-680.
31. Vaughan C.W., Christie M.J. Increase by the ORL1 receptor (opioid receptor-like) ligand nociceptin, of inwardly rectifying K conductance in dorsal raphe nucleus neurones. Br J Pharmacol. 117:1996;1609-1611.
32. Wang J.B, Johnson P.S., Imai Y., Persico A.M., Ozenberger B.A., Eppler C.M., Uhl G.R. cDNA cloning of an orphan receptor gene family member and its splice variant. FEBS Lett. 348:1994;75-79.
33. Wick M.J., Minnerath S.R., Lin X., Elde R., Law P-Y., Loh H.H. Isolation of a novel cDNA encoding a putative membrane receptor with high homology to the cloned μ, δ and κ opioid receptors. Mol Brain Res. 27:1994;37-44.
34. Williams C.A., Wu S.Y., Cook J., Dun N.J. Release of nociceptin-like substance from the rat spinal cord dorsal horn. Neurosci Lett. 244:1998;141-144.
35. 2, a proposed antagonist of the nociceptin receptor, is a potent and stable agonist in the rat spinal cord. Neurosci Lett. 249:1998;127-130.
36. Yamamoto T., Nozaki-Taguchi N., Kimura S. Effects of intrathecally administered nociceptin, an opioid receptor-like 1 (ORL 1) receptor agonist, on the thermal hyperalgesia induced by carrageenan injection into the rat paw. Brain Res. 754:1997;329-332.